Tokai Pharmaceuticals Inc
Tokai Pharmaceuticals Inc (TKAI) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 48 transactions totaling $19.2M, demonstrating a bullish sentiment with $13.2M in net insider flow. The most recent transaction on Mar 15, 2016 involved a purchase of 8,000 shares valued at $45.9K.
TKAI Insider Activity Summary
Who Is Buying TKAI Stock?
No significant insider buying has been recorded for TKAI in the recent period.
Who Is Selling TKAI Stock?
No significant insider selling has been recorded for TKAI in the recent period.
Is Tokai Pharmaceuticals Inc Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for TKAI is bullish with an Insider Alignment Score of 84/100 and a net flow of $13.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
TKAI Frequently Asked Questions
Understanding TKAI Insider Activity
Insider trading at Tokai Pharmaceuticals Inc (TKAI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading TKAI stock, having executed 48 transactions in the past 90 days. The most active insider is Ag Novartis (Executive), who has made 9 transactions totaling $6.6M.
Related Tools
Track Tokai Pharmaceuticals Inc Insider Activity
Get notified when executives and directors at TKAI file new Form 4 transactions